Cargando…
Neuropsychological differences between treatment-resistant and treatment-responsive schizophrenia: a meta-analysis
Antipsychotic treatment resistance affects up to a third of individuals with schizophrenia. Of those affected, 70–84% are reported to be treatment resistant from the outset. This raises the possibility that the neurobiological mechanisms of treatment resistance emerge before the onset of psychosis a...
Autores principales: | Millgate, Edward, Hide, Olga, Lawrie, Stephen M, Murray, Robin M, MacCabe, James H, Kravariti, Eugenia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711103/ https://www.ncbi.nlm.nih.gov/pubmed/36415088 http://dx.doi.org/10.1017/S0033291721004128 |
Ejemplares similares
-
S62. COGNITIVE DEFICITS IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Millgate, Edward, et al.
Publicado: (2020) -
Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study
por: Millgate, Edward, et al.
Publicado: (2021) -
Neuropsychological function at first episode in treatment-resistant psychosis: findings from the ÆSOP-10 study
por: Kravariti, Eugenia, et al.
Publicado: (2019) -
Predictors of treatment resistant schizophrenia: a systematic review of prospective observational studies
por: Smart, S. E., et al.
Publicado: (2021) -
41. RECONSIDERING THE EVIDENCE FOR CLOZAPINE FOR TREATMENT REFRACTORY SCHIZOPHRENIA
por: MacCabe, James
Publicado: (2018)